期刊文献+

早期大鼠实验性糖尿病视网膜病变模型的建立及观察 被引量:7

Establishment and evaluation of experimental early-stage diabetic retinopathy in rat
下载PDF
导出
摘要 目的建立链脲佐菌素(STZ)诱导的糖尿病大鼠视网膜病变病理模型并评价其应用价值。方法34只封闭群Wistar大鼠分为正常对照组(CON)、糖尿病3个月组(DM3)和糖尿病6个月组(DM6),采用化学药物STZ大剂量一次性腹腔注射建立糖尿病大鼠模型,观察各组大鼠一般生理指标,并对糖尿病模型大鼠进行视网膜组织病理学检查及血管内皮生长因子(VEGF)免疫组化检测。结果STZ腹腔注射大鼠成模率100%,DM3组及DM6组大鼠视网膜均出现程度不等的水肿、血管扩张和细胞排列紊乱等改变,DM6组更加显著。视网膜VEGF表达阳性细胞率在DM3组为38%,DM6组为89%。结论STZ诱导的糖尿病大鼠在病程6个月以上时可作为早期类似人类背景型糖尿病视网膜病变的模型。 Objective To establish a model of early diabetic retinopathy in rat and study the retinal changes by histopathology. Methods 34 Wistar rats were divided into three groups: CON (normal control), DM3 (diabetes for3 months) and DM6 (diabetes for 6 months). The diabetic rat model was induced by intraperitoneal injection of streptozotocin (STZ). The retinal pathology and the expression of vascular endothelial growth factor (VEGF) in retina were studied. Results Diabetic model was successfully induced in all rats with STZ ip. Retinal lesions of varied degrees were found in DM3 and DM6 groups. The retina edema, microangium expansion and disorder of celluar arrangement were more severe in DM6 than in DM3 group. The positive rate of retinal VEGF expression in DM3 and DM6 groups was 38 % and 89 %, respectively. Conclusion The diabetic retinopathy model in rat with STZ - induced diabetes for 6 months, may represent the early stage of human background diabetic retinopathy.
作者 李明新
出处 《徐州医学院学报》 CAS 2005年第5期436-440,共5页 Acta Academiae Medicinae Xuzhou
关键词 糖尿病视网膜病变 视网膜 病理生理学 血管内皮生长因子 疾病模型 大鼠 diabetic retinopathy retina, pathophysiology vascular endothehal growth factor disease model, rat
  • 相关文献

参考文献12

  • 1Archer DB. Diabetic retinopathy: investigation and therapeutic strategies for the new millennium [J]. Ophthal Physiol Opt, 2000, 20(2):S3- S4.
  • 2黄松,洗苏.糖尿病动物模型研究现状及进展[J].广西医学,2002,24(1):46-48. 被引量:53
  • 3黄波,刘学政,庞东渤.不同途径注射链脲佐菌素致大鼠糖尿病模型的研究[J].锦州医学院学报,2003,24(1):19-21. 被引量:57
  • 4邓华菲.糖尿病动物模型的建立[J].郴州医学高等专科学校学报,2002,4(1):27-28. 被引量:2
  • 5Pe'er J, Shweiki D, Itin A, et al. Hypoxia- induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases [J]. Lab Invest, 1995,72(6) :638 -645.
  • 6Murata T, Nakagawa K, Khalil A, et al. The relation between expression of vascular endothelial growth factor and breakdown of the bloodretinal barrier in diabetic rat retinas [J]. Lab Invest, 1996,74(4):819 - 825.
  • 7Hammes HP, Lin J, Bretzel RG, et al. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat [J].Diabetes, 1998,47(3) :401 - 406.
  • 8Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [J].Biochem Biophys Res Conlmum, 1989,161(2): 851 - 858.
  • 9King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications [J]. Endocrinol Metab Clin North Am, 1996,25(2) :255 - 270.
  • 10Porta M. Endothelium: the main actor in the remodeling of the retinal microvasculature in diabetes [J]. Diabetologia, 1996,39(6): 739 -744.

二级参考文献15

共引文献120

同被引文献105

引证文献7

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部